| Acquired by | Cephalon |
| Price | $250M |
| Date | 2/10 |
| Website | ceptiontx.com |
| Category | BioTech |
| Phone | 610.640.2940 |
| contactus@ception... | |
| Employees |
| TOTAL | $77.7M |
| FUNDING TOTAL | $77.7M |
| Series C, 1/07 Essex Woodlands Health Ventures Growth Capital Fund MDS Capital New Science Ventures Aperture Venture Partners | $63M |
| Series C, 5/07 Third Point Ventures Greenlight Capital | $14.7M |
Ception Therapeutics is a biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need.
Ception was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need.
